DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Allergy Sinus Pain - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Allergy Sinus Pain - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...
January 2022
60 pages
Allogenic Cell Therapies - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Allogenic Cell Therapies - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
Allogenic iNKT cell therapy - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Allogenic iNKT cell therapy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...
January 2022
60 pages
Alopecia Areata - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Alopecia Areata - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Alpha-Mannosidosis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Alpha-Mannosidosis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...
January 2022
60 pages
Alpha-synuclein inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Alpha-Synuclein Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ p...
January 2022
60 pages
Alpha Thalassemia - Epidemiology Forecast–2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Alpha Thalassemia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Alpha4beta7 integrin antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Alpha4beta7 integrin antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 7+ companies and...
January 2022
60 pages
Alport Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Alport Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Alstrom Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Alstrom Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...
January 2022
60 pages
Amblyopia - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Amblyopia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical a...
January 2022
60 pages
Amebiasis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Amebiasis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical a...
January 2022
60 pages
Aminopeptidase inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Aminopeptidase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies an...
January 2022
60 pages
Amyloid beta-protein inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Amyloid Beta-Protein Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and...
January 2022
60 pages
Amyloidosis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Amyloidosis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
Anal Fissure - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Anal Fissure - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...
January 2022
60 pages
Anal Fistula - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Anal Fistula - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...
January 2022
60 pages
Anaphylaxis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Anaphylaxis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
ANCA Vasculitis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'ANCA Vasculitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Androgen receptor antagonists - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Androgen receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 20+ companies and 20...
January 2022
60 pages
Androgenetic Alopecia - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Androgenetic Alopecia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Anemia in Elderly - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Anemia in Elderly - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Anesthetic Effect - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Anesthetic Effect - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
